Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Natural Health Trends (NHTC) over the last 16 years, with Q3 2025 value amounting to $267000.0.

  • Natural Health Trends' Gains from Investment Securities rose 29777.78% to $267000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 5902.17%. This contributed to the annual value of $4.0 million for FY2024, which is 1215.64% up from last year.
  • Per Natural Health Trends' latest filing, its Gains from Investment Securities stood at $267000.0 for Q3 2025, which was up 29777.78% from $180000.0 recorded in Q2 2025.
  • Natural Health Trends' 5-year Gains from Investment Securities high stood at $4.3 million for Q4 2024, and its period low was -$316000.0 during Q2 2024.
  • Its 5-year average for Gains from Investment Securities is $645277.8, with a median of $108500.0 in 2021.
  • As far as peak fluctuations go, Natural Health Trends' Gains from Investment Securities soared by 576521.74% in 2021, and later tumbled by 102941.18% in 2024.
  • Natural Health Trends' Gains from Investment Securities (Quarter) stood at $1.3 million in 2021, then rose by 19.94% to $1.6 million in 2022, then soared by 112.42% to $3.4 million in 2023, then rose by 25.34% to $4.3 million in 2024, then plummeted by 93.8% to $267000.0 in 2025.
  • Its Gains from Investment Securities was $267000.0 in Q3 2025, compared to $180000.0 in Q2 2025 and $154000.0 in Q1 2025.